CHO Pharma, Inc is a pharmaceutical company. They develop new drugs through their CHOptimaX technology platform, with a focus on candidate drugs for HER2. Their products include glycoengineered biobetter antibodies and next-generation antibody drugs targeted at HER2.
Headquarters
7F., No. 99, Ln. 130, Sec. 1,Academia Rd., Nangang Dist
Taipei City; Taipei City;
Contact Details: Purchase the CHO Pharma, Inc. (醣基生医股份有限公司) report to view the information.
Website: http://www.chopharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service